Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2

Ian Arthur Akers1, Maddy Parsons1, Michael Hill1, Morley D. Hollenberg2, Shahin Sanjar3, Geoffrey J. Laurent1, Robin J. McAnulty1
1Centre for Cardiopulmonary Biochemistry and Respiratory Medicine, The Royal Free and University College Medical School, The Rayne Institute, London WC1E 6JJ;
2Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada T2N 4N1
3Respiratory Diseases Unit, Glaxo Wellcome Research and Development Limited, Medicines Research Centre, Stevenage SG1 2NY, United Kingdom; and

Tóm tắt

Mast cells play a potentially important role in fibroproliferative diseases, releasing mediators including tryptase that are capable of stimulating fibroblast proliferation and procollagen synthesis. The mechanism by which tryptase stimulates fibroblast proliferation is unclear, although recent studies suggest it can activate protease-activated receptor (PAR)-2. We therefore investigated the role of PAR-2 in tryptase-induced proliferation of human fetal lung and adult lung parenchymal and airway fibroblasts and, for comparative purposes, adult dermal fibroblasts. Tryptase (0.7–70 mU/ml) induced concentration-dependent increases in proliferation of all fibroblasts studied. Antipain, bis(5-amidino-2-benzimidazolyl)methane, and benzamidine inhibited tryptase-induced fibroblast proliferation, demonstrating that proteolytic activity is required for the proliferative effects of tryptase. RT-PCR demonstrated the presence of PAR-2 mRNA, and immunohistochemical staining localized PAR-2 to the cell surface of lung fibroblasts. In addition , specific PAR-2 activating peptides, SLIGKV and SLIGRL, mimicked the proliferative effects of tryptase. In contrast, human dermal fibroblasts only weakly stained with the PAR-2 antibody, PAR-2 mRNA was almost undetectable, and fibroblasts did not respond to PAR-2 activating peptides. These results suggest that tryptase induces lung, but not dermal, fibroblast proliferation via activation of PAR-2 and are consistent with the hypothesis that the release of tryptase from activated mast cells may play an important role in the fibroproliferative response observed in asthma, chronic obstructive pulmonary disease, and patients with pulmonary fibrosis.

Từ khóa


Tài liệu tham khảo

10.1136/thx.40.10.760

10.1139/y95-172

10.1042/bj3200939

10.1074/jbc.271.28.16466

10.1074/jbc.271.36.22003

10.1042/bj3141009

10.1165/ajrcmb/3.5.507

10.1165/ajrcmb.13.2.7626290

Cairns J. A., 1996, J. Immunol., 156, 275, 10.4049/jimmunol.156.1.275

10.1172/JCI119290

10.1164/ajrccm/138.6.1604

Caughey G. H., 1993, J. Pharmacol. Exp. Ther., 264, 676

10.1164/ajrccm/147.6_Pt_1.1497

10.1172/JCI119658

10.1111/j.1365-2559.1978.tb01735.x

10.1177/002215549804600204

Derian C. K., 1997, Cell Growth Differ., 8, 743

10.1152/ajpcell.1998.274.6.C1429

Djukanovic R., 1992, Eur. Respir. J., 5, 538, 10.1183/09031936.93.05050538

10.1164/ajrccm/143.4_Pt_1.772

Eklund A., 1993, Sarcoidosis, 10, 12

10.1016/0091-6749(92)90133-M

Fortoul T. I., 1990, Arch. Invest. Med. (Mex.), 21, 5

10.1016/S0014-5793(97)01298-2

Gruber B. L., 1997, J. Immunol., 158, 2310, 10.4049/jimmunol.158.5.2310

10.1152/ajplung.1992.262.5.L528

10.1002/path.1711660314

10.1139/y97-110

10.1016/S0025-6196(12)60924-0

10.1161/01.RES.78.4.581

10.1038/386502a0

10.1038/29325

Kawanami O., 1979, Lab. Invest., 40, 717

10.1073/pnas.94.16.8884

10.1074/jbc.271.24.13943

10.1016/0167-5273(96)02569-7

McAnulty R. J., 1995, Exp. Nephrol., 3, 96

10.1378/chest.105.4.1184

Mirza H., 1997, Blood, 90, 3914, 10.1182/blood.V90.10.3914

10.1172/JCI118597

10.1074/jbc.272.7.4043

10.1074/jbc.272.17.11133

10.1111/j.1432-1033.1995.tb20784.x

10.1073/pnas.91.20.9208

10.1074/jbc.271.25.14910

Oliver M. H., 1989, J. Cell Sci., 92, 513, 10.1242/jcs.92.3.513

10.1038/32703

10.1378/chest.103.4.989

10.1378/chest.100.5.1197

10.1111/j.1432-1033.1996.00619.x

10.1016/0091-6749(87)90158-8

10.1016/S0140-6736(89)90067-6

10.1172/JCI115330

10.1111/j.1476-5381.1996.tb15433.x

10.1073/pnas.92.20.9151

10.1002/(SICI)1097-4652(199808)176:2<365::AID-JCP15>3.0.CO;2-2

10.1016/S0049-3848(96)00214-9

10.1515/bchm3.1992.373.2.1025

Tomioka M., 1984, Am. Rev. Respir. Dis., 129, 1000

10.1073/pnas.95.13.7766

10.1016/0092-8674(91)90261-V

10.1042/cs0810183

10.1016/0006-2952(92)90498-8

10.1159/000235183

10.1164/ajrccm/137.5.1002

10.1073/pnas.95.12.6642